GNI Group Ltd. (2160.T)
JPY 1828.0
(0.66%)
JPY 1828.0
(0.66%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 62.39 Billion JPY | 84.02% |
| 2022 | 33.9 Billion JPY | 11.92% |
| 2021 | 30.29 Billion JPY | 30.48% |
| 2020 | 23.21 Billion JPY | 12.67% |
| 2019 | 20.6 Billion JPY | 18.9% |
| 2018 | 17.33 Billion JPY | 9.14% |
| 2017 | 15.87 Billion JPY | 172.9% |
| 2016 | 5.81 Billion JPY | -8.88% |
| 2015 | 6.38 Billion JPY | -5.57% |
| 2014 | 6.76 Billion JPY | 42.31% |
| 2013 | 4.75 Billion JPY | 202.61% |
| 2012 | 1.57 Billion JPY | 0.29% |
| 2011 | 1.56 Billion JPY | 62.79% |
| 2010 | 961.81 Million JPY | 0.0% |
| 2008 | 1.23 Billion JPY | -52.15% |
| 2007 | 2.58 Billion JPY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 65.6 Billion JPY | 5.14% |
| 2024 Q2 | 68.99 Billion JPY | 5.17% |
| 2023 Q1 | 34.07 Billion JPY | 0.48% |
| 2023 Q4 | 62.39 Billion JPY | 28.73% |
| 2023 Q3 | 48.46 Billion JPY | 7.58% |
| 2023 Q2 | 45.05 Billion JPY | 32.23% |
| 2023 FY | 62.39 Billion JPY | 84.02% |
| 2022 Q3 | 36.45 Billion JPY | 3.37% |
| 2022 Q4 | 33.9 Billion JPY | -6.99% |
| 2022 FY | 33.9 Billion JPY | 11.92% |
| 2022 Q1 | 32.59 Billion JPY | 7.57% |
| 2022 Q2 | 35.26 Billion JPY | 8.21% |
| 2021 Q1 | 27.11 Billion JPY | 16.79% |
| 2021 Q3 | 29.78 Billion JPY | 2.76% |
| 2021 Q4 | 30.29 Billion JPY | 1.71% |
| 2021 FY | 30.29 Billion JPY | 30.48% |
| 2021 Q2 | 28.99 Billion JPY | 6.91% |
| 2020 Q3 | 21.88 Billion JPY | 2.93% |
| 2020 Q2 | 21.26 Billion JPY | -0.08% |
| 2020 FY | 23.21 Billion JPY | 12.67% |
| 2020 Q4 | 23.21 Billion JPY | 6.08% |
| 2020 Q1 | 21.28 Billion JPY | 3.28% |
| 2019 Q1 | 17.97 Billion JPY | 3.71% |
| 2019 FY | 20.6 Billion JPY | 18.9% |
| 2019 Q4 | 20.6 Billion JPY | 1.11% |
| 2019 Q3 | 20.38 Billion JPY | 6.91% |
| 2019 Q2 | 19.06 Billion JPY | 6.06% |
| 2018 Q4 | 17.33 Billion JPY | 7.81% |
| 2018 Q2 | 15.84 Billion JPY | 1.85% |
| 2018 FY | 17.33 Billion JPY | 9.14% |
| 2018 Q3 | 16.07 Billion JPY | 1.43% |
| 2018 Q1 | 15.56 Billion JPY | -2.0% |
| 2017 Q1 | 5.82 Billion JPY | 0.16% |
| 2017 Q4 | 15.87 Billion JPY | 8.23% |
| 2017 FY | 15.87 Billion JPY | 172.9% |
| 2017 Q3 | 14.67 Billion JPY | 19.11% |
| 2017 Q2 | 12.31 Billion JPY | 111.34% |
| 2016 Q2 | 5.48 Billion JPY | -9.75% |
| 2016 Q4 | 5.81 Billion JPY | 7.66% |
| 2016 Q3 | 5.4 Billion JPY | -1.42% |
| 2016 FY | 5.81 Billion JPY | -8.88% |
| 2016 Q1 | 6.07 Billion JPY | -4.86% |
| 2015 FY | 6.38 Billion JPY | -5.57% |
| 2015 Q3 | 6.47 Billion JPY | -4.32% |
| 2015 Q2 | 6.76 Billion JPY | -1.28% |
| 2015 Q1 | 6.85 Billion JPY | 1.4% |
| 2015 Q4 | 6.38 Billion JPY | -1.41% |
| 2014 FY | 6.76 Billion JPY | 42.31% |
| 2014 Q2 | 6.2 Billion JPY | -3.42% |
| 2014 Q4 | 6.76 Billion JPY | 2.99% |
| 2014 Q3 | 6.56 Billion JPY | 5.75% |
| 2014 Q1 | 6.42 Billion JPY | 35.28% |
| 2013 Q2 | 2.04 Billion JPY | 36.52% |
| 2013 Q3 | 1.84 Billion JPY | -10.16% |
| 2013 FY | 4.75 Billion JPY | 202.61% |
| 2013 Q4 | 4.75 Billion JPY | 158.2% |
| 2013 Q1 | 1.5 Billion JPY | -4.45% |
| 2012 FY | 1.57 Billion JPY | 0.29% |
| 2012 Q1 | 1.91 Billion JPY | 22.11% |
| 2012 Q2 | 1.78 Billion JPY | -6.75% |
| 2012 Q3 | 1.62 Billion JPY | -8.58% |
| 2012 Q4 | 1.57 Billion JPY | -3.66% |
| 2011 Q2 | 876.99 Million JPY | -8.47% |
| 2011 Q4 | 1.56 Billion JPY | 24.01% |
| 2011 FY | 1.56 Billion JPY | 62.79% |
| 2011 Q3 | 1.26 Billion JPY | 43.98% |
| 2011 Q1 | 958.17 Million JPY | -0.38% |
| 2010 Q1 | 1.03 Billion JPY | 0.0% |
| 2010 FY | 961.81 Million JPY | 0.0% |
| 2010 Q3 | 931.72 Million JPY | 0.16% |
| 2010 Q2 | 930.23 Million JPY | -10.0% |
| 2010 Q4 | 961.81 Million JPY | 3.23% |
| 2009 Q3 | 887.86 Million JPY | -16.5% |
| 2009 Q2 | 1.06 Billion JPY | -14.14% |
| 2009 Q1 | 1.23 Billion JPY | -11.99% |
| 2008 FY | 1.23 Billion JPY | -52.15% |
| 2008 Q4 | 1.4 Billion JPY | 0.0% |
| 2007 FY | 2.58 Billion JPY | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 6.58 Billion JPY | -846.901% |
| PRISM BioLab Co.,LTD | 1.21 Billion JPY | -5050.49% |
| Linical Co., Ltd. | 18.53 Billion JPY | -236.541% |
| Trans Genic Inc. | 9.81 Billion JPY | -535.963% |
| MEDINET Co., Ltd. | 5.63 Billion JPY | -1007.433% |
| Soiken Holdings Inc. | 6.94 Billion JPY | -798.26% |
| Cytori Cell Research Institute, Inc. | 5.81 Billion JPY | -972.744% |
| AnGes, Inc. | 28.89 Billion JPY | -115.953% |
| OncoTherapy Science, Inc. | 867.27 Million JPY | -7094.301% |
| Nxera Pharma Co., Ltd. | 157.19 Billion JPY | 60.308% |
| Immuno-Biological Laboratories Co., Ltd. | 1.61 Billion JPY | -3754.879% |
| NanoCarrier Co., Ltd. | 5.07 Billion JPY | -1130.348% |
| Carna Biosciences, Inc. | 4.34 Billion JPY | -1334.389% |
| CanBas Co., Ltd. | 2.43 Billion JPY | -2464.656% |
| D. Western Therapeutics Institute, Inc. | 2.37 Billion JPY | -2528.935% |
| RaQualia Pharma Inc. | 6.93 Billion JPY | -800.316% |
| Chiome Bioscience Inc. | 1.75 Billion JPY | -3462.433% |
| Kidswell Bio Corporation | 5.08 Billion JPY | -1126.895% |
| PeptiDream Inc. | 67.12 Billion JPY | 7.05% |
| Oncolys BioPharma Inc. | 2.04 Billion JPY | -2957.651% |
| Ribomic Inc. | 3.54 Billion JPY | -1658.947% |
| SanBio Company Limited | 5.04 Billion JPY | -1136.195% |
| Healios K.K. | 15.15 Billion JPY | -311.708% |
| BrightPath Biotherapeutics Co., Ltd. | 1.23 Billion JPY | -4971.653% |
| Kubota Pharmaceutical Holdings Co., Ltd. | 3.01 Billion JPY | -1968.779% |
| Delta-Fly Pharma, Inc. | 1.47 Billion JPY | -4132.552% |
| StemRIM | 9.08 Billion JPY | -587.163% |
| CellSource Co., Ltd. | 6.87 Billion JPY | -806.93% |
| FunPep Company Limited | 2.49 Billion JPY | -2404.657% |
| Kringle Pharma, Inc. | 2.61 Billion JPY | -2282.686% |
| Stella Pharma Corporation | 3.82 Billion JPY | -1533.095% |
| TMS Co., Ltd. | 3.55 Billion JPY | -1655.237% |
| Noile-Immune Biotech Inc. | 5.77 Billion JPY | -979.684% |
| Cuorips Inc. | 6.18 Billion JPY | -908.844% |
| K Pharma,Inc. | 3.31 Billion JPY | -1782.807% |
| Takara Bio Inc. | 123.2 Billion JPY | 49.358% |
| ReproCELL Incorporated | 9.05 Billion JPY | -589.24% |
| PhoenixBio Co., Ltd. | 2.71 Billion JPY | -2197.864% |
| StemCell Institute Inc. | 6.54 Billion JPY | -853.594% |
| Japan Tissue Engineering Co., Ltd. | 6.98 Billion JPY | -792.78% |
| CellSeed Inc. | 2.46 Billion JPY | -2430.423% |